CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity and Safety Study of GSK Biologicals' Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02096263
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:29.830105+00:00
Published At: 2018-08-01T00:00:00+00:00
Record Updated At: 2019-11-27
Results Posted At: 2018-08-01
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Poliomyelitis", "Diphtheria", "Haemophilus Influenzae Type b", "Tetanus", "Acellular Pertussis", "Hepatitis B"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-11-27"
protocolSection.identificationModule.nctId: "NCT02096263"
protocolSection.identificationModule.officialTitle: "Immunogenicity and Safety Study of GSK Biologicals\u0027 Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2018-08-01"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.